A Double-blind, Placebo-controlled Study of Antidepressant Augmentation With Agomelatine

NCT04589143 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Agomelatine
DRUG: Placebos

Sponsor

Central South University